additional outperformance over the remainder of the year, and the divestment of the AMS business later this year to Boston Scientific should give management greater resources for finding value-accretive deals, including the May 11 announcement
soft demand for vaginal slings and penile implants. We expect Coloplast will refocus on penile implants now that Boston Scientific will soon close on its purchase of the men's urology business from Endo Pharmaceuticals. We anticipate Boston
Boston Scientific 's solid first-quarter results were largely consistent with our projections, and we are leaving our $13 fair value estimate
April 28 (Reuters) - Boston Scientific Corp on Tuesday said it reached its first settlement agreement to resolve a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.
April 28 (Reuters) - Boston Scientific Corp on Tuesday said it has reached an agreement to settle a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.
April 28 (Reuters) - Boston scientific says it reached conditional agreement to settle some transvaginal mesh cases Boston scientific says it will pay about $119 million to resolve 2,970 cases Boston...
April 28 (Reuters) - Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits.
April 28 (Reuters) - Medical device maker Boston Scientific Corp reported a quarterly net loss due to one-time charges, including litigation costs of $193 million.
surgeon and interventional cardiologist teams that are already trained on the Sapien valve, we suspect St. Jude and Boston Scientific face a challenge in ramping up their own trained physician teams.
firm's exposure to liability is limited, especially compared with Johnson & Johnson, Endo Pharmaceuticals, and Boston Scientific . The firm settled 400 of the cases for $16 million, or roughly $20,000 per plaintiff. This is significantly